Home Blue Sail Medical's Investee Company Suzhou CH Biomed Receives NMPA Approval for Implantable Left Ventricular Assist Device

Blue Sail Medical's Investee Company Suzhou CH Biomed Receives NMPA Approval for Implantable Left Ventricular Assist Device

Nov 25, 2021 20:31 CST Updated 20:31
Bluesail Medical

Producers of Medium-Low Value Consumables and High-Value Medical Devices

BrioHealth Solutions

Ventricular Assist Device Developer and Manufacturer

Gelonghui November 25th丨Bluesail Medical (002382.SZ) announced that the innovative product "Implantable Left Ventricular Assist System" developed by its participating company, BrioHealth Solutions ("BrioHealth"), received Class III medical device registration approval from the National Medical Products Administration today. Details are as follows: